Accelerating Innovation for Pediatric ARV Formulations: Review of Progress of Mutual Accountability Framework
This stakeholder briefing took place at the 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention. The briefing included updates from the Paediatric Treatment Initiative and the Global Pediatric ARV Commitment-to‐Action.
DNDi’s Head of Paediatric HIV Programme, Marc Lallemant, took part in a high-level panel discussion on overcoming challenges and advancing opportunities to accelerate product innovation and market uptake of new pediatric ARV formulations.
Date: July 21, 2015
Moderated by: Dr Robert Hecht, Managing Director, Results for Development Institute